ÂÜÀòÂÒÂ×

Ana Serrano Puebla, PhD, has extensive work experience in the healthcare and research fields. Ana is currently working at Medable, Inc as a Patient & Site Adoption Lead, facilitating the adoption of Medable's patient-centric platform. Prior to that, they worked at Cancer Trials Ireland as a Clinical Trial Specialist, overseeing the management of clinical trials.

In 2020, Ana worked at EY as an R&D Consultant, specializing in innovation incentives for the life science and clinical sector. Their responsibilities included client interviews, project management, and delivering high-quality solutions to clients.

Before joining EY, they were a Postdoctoral Researcher at Københavns Universitet (University of Copenhagen), sponsored by Novo Nordisk Foundation. Ana also gained research experience at CSIC, where they held roles as a Postdoctoral Researcher, PhD Biomedical Scientist, and participated in a Postgraduate Internship Program.

Overall, Ana Serrano Puebla, PhD, has a diverse background in research, clinical trials, innovation incentives, and patient adoption strategies, making their a valuable asset in the healthcare industry.

Ana Serrano Puebla, PhD, obtained a Bachelor's and Master's degree in Cellular and Molecular Biology from Universidad Autónoma de Madrid from 2008 to 2013. Ana then pursued a PhD in Biomedicine at Universidad Complutense de Madrid from 2014 to 2018. In 2019 to 2020, Ana completed their Master of Business Administration (MBA) with a specialization in Business Expert at ThePower Business School. Ana has also obtained additional certifications, including a DCT Foundation Certification from Medable, Inc in April 2022 and ICH GCP (E6) R2 Certification from Cancer Trials Ireland in October 2021.